{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:34:45Z","timestamp":1779291285768,"version":"3.51.4"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T00:00:00Z","timestamp":1295827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. In the absence of human cases of smallpox, new treatments must be tested for efficacy in animal models. Previously, we demonstrated the efficacy of CMX001 in protecting New Zealand White rabbits from mortality following intradermal infection with rabbitpox virus as a model for smallpox, monkeypox and for treatment of adverse reactions to smallpox vaccination. Here we extend these studies by exploring different dosing regimens and performing randomized, blinded, placebo-controlled studies. In addition, because rabbitpox virus can be transmitted via naturally generated aerosols (animal to animal transmission), we report on studies to test the efficacy of CMX001 in protecting rabbits from lethal rabbitpox virus disease when infection occurs by animal to animal transmission. In all cases, CMX001 treatment was initiated at the onset of observable lesions in the ears to model the use of CMX001 as a treatment for symptomatic smallpox. The results demonstrate that CMX001 is an effective treatment for symptomatic rabbitpox virus infection. The rabbitpox model has key similarities to human smallpox including an incubation period, generalized systemic disease, the occurrence of lesions which may be used as a trigger for initiating therapy, and natural animal to animal spread, making it an appropriate model.<\/jats:p>","DOI":"10.3390\/v3010047","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T09:21:39Z","timestamp":1295860899000},"page":"47-62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans"],"prefix":"10.3390","volume":"3","author":[{"given":"Amanda D.","family":"Rice","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew M.","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Burrage","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott F.","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Swetnam","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi R.","family":"Manning","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey A.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Lampert","sequence":"additional","affiliation":[{"name":"Chimerix, Inc., 2505 Meridian Parkway Suite, 340 Durham, NC 27713, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Foster","sequence":"additional","affiliation":[{"name":"Chimerix, Inc., 2505 Meridian Parkway Suite, 340 Durham, NC 27713, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall","family":"Lanier","sequence":"additional","affiliation":[{"name":"Chimerix, Inc., 2505 Meridian Parkway Suite, 340 Durham, NC 27713, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Robertson","sequence":"additional","affiliation":[{"name":"Chimerix, Inc., 2505 Meridian Parkway Suite, 340 Durham, NC 27713, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Painter","sequence":"additional","affiliation":[{"name":"Chimerix, Inc., 2505 Meridian Parkway Suite, 340 Durham, NC 27713, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Moyer","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2011,1,24]]},"reference":[{"key":"ref_1","unstructured":"(1996). FDA grants marketing clearance of Vistide for the treatment of CMV retinitis. AIDS Patient Care STDS, 10, 383\u2013384."},{"key":"ref_2","unstructured":"Food and Drug Administration (1996). FDA approves cidofovir for treatment of CMV retinitis. J. Int. Assoc. Phys. AIDS Care, 2, 30."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.46.5.1329-1335.2002","article-title":"Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses","volume":"46","author":"Smee","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00380-06","article-title":"Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype","volume":"50","author":"Kornbluth","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1399-3046.2008.00937.x","article-title":"Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy","volume":"12","author":"Araya","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tibtech.2004.06.008","article-title":"Design and development of oral drugs for the prophylaxis and treatment of smallpox infection","volume":"22","author":"Painter","year":"2004","journal-title":"Trends Biotechnol."},{"key":"ref_11","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, A., and Ladnyi, I.D. (1988). Smallpox and Its Eradication, World Health Organization."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1128\/JVI.00423-07","article-title":"Rabbitpox Virus and Vaccinia Virus Infection of Rabbits as a Model for Human Smallpox","volume":"81","author":"Adams","year":"2007","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2009.06.105","article-title":"Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model","volume":"27","author":"Garza","year":"2009","journal-title":"Vaccine"},{"key":"ref_15","first-page":"S34","article-title":"Rabbitpox: An Aerosol Model for the Study of Aerosolized Poxviruses","volume":"43","author":"Roy","year":"2004","journal-title":"J. Antivir. Res."},{"key":"ref_16","first-page":"289","article-title":"Pathology of aerosolized rabbitpox virus infection in rabbits","volume":"14","author":"Roy","year":"2006","journal-title":"Vet. Pathol."},{"key":"ref_17","unstructured":"Foster, S. (2010). Chimerix, Inc., Durham, NC, USA. Unpublished work."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0026-895X(25)08828-5","article-title":"Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_19","unstructured":"Rice, A.D., Adams, M.M., Lampert, B., Foster, S., Lanier, R., Robertson, A., Painter, G., and Moyer, R.W. Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans. Viruses, in press."},{"key":"ref_20","unstructured":"Rice, A.D., and Moyer, R.W. (2009). University of Florida, Gainesville, FL, USA. Unpublished work."},{"key":"ref_21","unstructured":"Rice, A.D., and Moyer, R.W. (2010). University of Florida, Gainesville, FL, USA. Unpublished work."},{"key":"ref_22","first-page":"453","article-title":"Experimental respiratory infection with poxviruses. I. Clinical virological and epidemiological studies","volume":"47","author":"Westwood","year":"1966","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_23","unstructured":"Fenner, F., Henderson, D. A., Arita, I., Jezek, Z., and Ladnyi, I. D. (1988). Smallpox and Its Eradication, World Health Organization."},{"key":"ref_24","unstructured":"Rao, A.R. (1972). Smallpox, The Kothari Book Depot."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/milmed\/167.7.546","article-title":"The cause of death in smallpox: An examination of the pathology record","volume":"167","author":"Martin","year":"2002","journal-title":"Mil. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0042-6822(81)90150-1","article-title":"Isolation and preliminary characterization of temperature- sensitive mutants of vaccinia virus","volume":"113","author":"Condit","year":"1981","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0042-6822(83)90268-4","article-title":"Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus","volume":"128","author":"Condit","year":"1983","journal-title":"Virology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/3\/1\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:55:01Z","timestamp":1760219701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/3\/1\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1]]}},"alternative-id":["v3010047"],"URL":"https:\/\/doi.org\/10.3390\/v3010047","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,24]]}}}